E-DRUG: Pemoline withdrawn in the U.K.
--------------------------------------
Dear E-druggers,
I just came to know about the website of the Medicine Control Agency
(MCA)/Committee on Safety of Medicines (CSM) in the U.K. The URL is
http://www.open.gov.uk. Once in the website double click on
"Organizational index" and then on "M" and then on MCA. I think this
site will be useful to many e-druggers.
I am reproducing below a news about the withdrawal of pemoline from
the U.K. Those who have direct internet access can see the full text
of the publication Current Problems on the above website.
Pemoline is a central nervous stimulant indicated in attention
deficit hyperactivity disorder (ADHD).
It is interesting to note that the decision in the U.K. was based
on cases reported in the U.S. However, to my knowledge pemoline has
not been withdrawn in the U.S. However, the product labeling for
pemoline (brand name Cylert in the U.S.) was modified to include a
boxed warning describing liver failure and to indicate that pemoline
should not ordinarily be considered as first-line drug therapy for
attention deficit hyperactivity disorder (ADHD).
E-druggers, could you please report the status of pemoline in your
country? Thanks.
Syed Rizwanuddin Ahmad
E-drug moderator
Email: srahmad@essential.org